You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
瑞普生物(300119.SZ):生物製品端重點佈局多聯多價疫苗、基因工程苗和mRNA疫苗
格隆匯 04-03 15:01

格隆匯4月3日丨瑞普生物(300119.SZ)於近期投資者關係活動表示,生物製品端重點佈局多聯多價疫苗、基因工程苗和mRNA疫苗,家畜板塊重點推動市場首個豬圓支副三聯滅活疫苗上市,加快豬僞狂犬基因缺失滅活疫苗及豬流腹-輪狀二聯滅活疫苗等產品註冊;家禽板塊重點推動新支二聯疫苗、新流法腺四聯疫苗、新支流法四聯疫苗等多聯多價疫苗及腺病毒卵黃抗體、鴨肝炎二價卵黃抗體等新產品的上市,推動新支流法腺五聯疫苗、重組雞α-幹擾素口服液等產品註冊;水禽板塊重點推動鴨病毒性肝炎二價卵黃抗體上市,推動鴨細小病毒活疫苗、以及鴨細小-坦布蘇-呼腸孤三聯疫苗的研發上市。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account